Missing/wrong data?
Log in to edit
Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the HoT-PE Trial.
scientific article published on 24 March 2016
Author/s
author: Stefano Barco, Mareike Lankeit, Jan Beyer-Westendorf
Work details
Publication date
March 24, 2016
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.